HAVCR2 and neoplasm: On the other hand, CD4 + and CD8 + T cells trigger tumour escape by expressing immune checkpoint molecules (PD-1, LAG-3, CTLA-4, TIM-3) that bind to their related ligands on DCs and/or tumours, thereby stopping an immune reaction [43].